WeVote
Log In

Bill

Bill

SJR 140

General Assembly, Recess & Reconvene - Recesses General Assembly from February 13, 2025, until February 20, 2025. -

114th Regular Session (2025-2026)

SJR 140 designates March as Amyloidosis Awareness Month in New Jersey to promote education, early diagnosis, and better quality of life, with annual gubernatorial proclamations.

Signed by Governor.
#generalassembly #recess&reconvene
0
WeVote Research Nonpartisan
Bill Summary · SJR 140

Summary: Senate Joint Resolution No. 140 (SJR 140) – Amyloidosis Awareness Month

Purpose and Intent

  • Designates the month of March in New Jersey as “Amyloidosis Awareness Month” each year.
  • Aims to educate the public about the signs and symptoms of amyloidosis, encourage earlier and more accurate diagnosis, and ultimately improve life expectancy and quality of life for those affected.
  • Requires the Governor to annually issue a proclamation urging public officials and residents to observe the month with appropriate activities and programs.

Key Provisions

  • Designation: The month of March is designated as Amyloidosis Awareness Month in New Jersey.
  • Annual Proclamation: The Governor is requested to issue an annual proclamation during March to observe Amyloidosis Awareness Month and promote related activities.
  • Effective Date: The joint resolution takes effect immediately.

Background and Rationale

  • Amyloidosis refers to a group of diseases characterized by the buildup of amyloid fibrils in tissues and organs, which can cause organ damage and diminished quality of life.
  • There are approximately 36 types of amyloidosis, with varying signs and symptoms depending on the type and organs affected.
  • Early and accurate diagnosis is challenging but critical; diagnosis typically requires tissue biopsy, as imaging and blood/urine tests may be inconclusive.
  • There is no cure; treatments focus on managing symptoms and reducing further production of amyloid proteins.

Who/What Is Affected

  • General public: Increased awareness about symptoms and the importance of early diagnosis.
  • People with amyloidosis: Potential improvements in detection, understanding, and access to timely care.
  • Health care providers and policymakers: Encouraged engagement in awareness activities and programs during March.
  • State officials: Governor’s annual proclamation and associated observances.

Fiscal and Administrative Considerations

  • The designation is largely symbolic and promotional; no specific funding or new programs are mandated by the text.
  • Administrative action centers on annual proclamations and public awareness activities during March.

Legislative History and Timeline

  • Introduced: October 10, 2024.
  • Senate Health, Human Services and Senior Citizens Committee: Reported favorably (December 9, 2024).
  • Senate: Passed (38-0) on February 25, 2025.
  • Assembly: Referred to Assembly Health Committee (February 25, 2025); Passed Assembly (76-0-0) on March 24, 2025 after substitution for AJR202 (companion resolution).
  • Joint Resolution: Approved as P.L.2025, JR-4 on March 31, 2025.
  • Related: Companion bill AJR 202 (Assembly Joint Resolution) exists.

Notable Points

  • The resolution is a commemorative/awareness measure, not a funding or program-enabling statute.
  • A companion bill (AJR 202) exists, indicating parallel recognition in the Assembly.

This bill, SJR 140, thus formally institutionalizes March as Amyloidosis Awareness Month in New Jersey to promote education, early diagnosis, and better quality of life for those affected, with annual gubernatorial proclamations to support awareness efforts.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.